EUVIMEDEUVIMED entdecken
Open Access

Targeting Mycolic Acid Biosynthesis with Cyclic Sulfamates: A New Strategy against Mycobacterium tuberculosis

Priscila Cristina Bartolomeu Halicki iD, Jed H Kim, Amory Francis Griffin, Daniel S Rampon iD, Kindra L Becker, Jessica C Seeliger iD, Jennifer M Schomaker iD, Kyle H Rohde iD

ACS Infectious Diseases · 2025

DOI: 10.1021/acsinfecdis.5c00419 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Infectious Diseases, 2025. Verfasst von Priscila Cristina Bartolomeu Halicki und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Immunity and Pathogenesis, Burnett School of Biomedical Sciences, College of Medicine, University of Central Florida, Orlando, Florida 32…. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Mycolic Acids, Antitubercular Agents, Sulfonic Acids. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NIH HHS, Division of Chemistry.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycobacterium tuberculosisMycolic AcidsAntitubercular AgentsSulfonic AcidsMicrobial Sensitivity TestsBacterial ProteinsHumansCell Wall3-Oxoacyl-(Acyl-Carrier-Protein) Synthase

Stichwörter der Autor:innen

cyclic sulfamatekasAmycolic acidnitrene transfersilvertuberculosis

Substanzen

Mycolic AcidsAntitubercular Agentssulfamic acidSulfonic AcidsBacterial Proteins3-Oxoacyl-(Acyl-Carrier-Protein) Synthase

Autor:innen und Institutionen

  • Division of Immunity and Pathogenesis, Burnett School of Biomedical Sciences, College of Medicine, University of Central Florida, Orlando, Florida 32827, United States.
  • Department of Chemistry, University of Wisconsin-Madison, Madison, Wisconsin 53076, United States.
  • Department of Chemistry, Stony Brook University, Stony Brook, New York 11794, United States.
  • Department of Chemistry and Pharmacological Sciences, Stony Brook University, Stony Brook, New York 11794, United States.

ORCID-Profile: Priscila Cristina Bartolomeu Halicki, Daniel S Rampon, Jessica C Seeliger, Jennifer M Schomaker, Kyle H Rohde

Förderung

  • NIAID NIH HHS
  • NIH HHS
  • Division of Chemistry
  • Medicinal Chemistry Division, American Chemical Society
  • National Institute of Allergy and Infectious Diseases
  • Pharmaceutical Research and Manufacturers of America Foundation

Zitieren

APA

Bartolomeu Halicki, P. C., Kim, J. H., Griffin, A. F., Rampon, D. S., Becker, K. L., Seeliger, J. C., Schomaker, J. M., & Rohde, K. H. (2025). Targeting Mycolic Acid Biosynthesis with Cyclic Sulfamates: A New Strategy against Mycobacterium tuberculosis. ACS Infectious Diseases. https://doi.org/10.1021/acsinfecdis.5c00419

Vancouver

Bartolomeu Halicki PC, Kim JH, Griffin AF, Rampon DS, Becker KL, Seeliger JC, et al. Targeting Mycolic Acid Biosynthesis with Cyclic Sulfamates: A New Strategy against Mycobacterium tuberculosis. ACS Infectious Diseases. 2025. doi:10.1021/acsinfecdis.5c00419

BibTeX
@article{BartolomeuHalicki2025,
  author = {Bartolomeu Halicki, Priscila Cristina and Kim, Jed H and Griffin, Amory Francis and Rampon, Daniel S and Becker, Kindra L and Seeliger, Jessica C and Schomaker, Jennifer M and Rohde, Kyle H},
  title = {Targeting Mycolic Acid Biosynthesis with Cyclic Sulfamates: A New Strategy against Mycobacterium tuberculosis},
  journal = {ACS Infectious Diseases},
  year = {2025},
  doi = {10.1021/acsinfecdis.5c00419}
}
Kostenlos starten →